1407P Real-world outcomes in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and tumors with androgen receptor (AR) 878/875 mutations

Autor: Stewart, T.F., Gedrich, R., Saha, J., Chirnomas, D., Edwards, M., Lang, J.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S1188-S1188
Databáze: ScienceDirect